Clinical Trial

Hyaluronic Acid Crosslinking Clinical Study

Study acronym: HACS
Active, Not Recruiting
View on ClinicalTrials.gov →
Summary
This prospective observational case series aims to evaluate the clinical efficacy, safety, and patient satisfaction associated with hyaluronic acid dermal fillers with different degrees of divinyl sulfone (DVS) crosslinking. Twenty adult participants undergoing facial aesthetic treatment will be followed for 90 days. Clinical outcomes will be assessed using three-dimensional imaging (Vectra® 3D), soft tissue ultrasonography, the Global Aesthetic Improvement Scale (GAIS), Net Promoter Score (NPS), Likert satisfaction scales, and standardized adverse event monitoring.
Trial Details
NCT Number NCT07744464
Lead Sponsor Antony de Paula Barbosa
Conditions Facial Aging, Skin Aging, Facial Volume Loss, Facial Rhytides, Nasolabial Fold, Lip Deformity, Jawline Contour Deformity, Chin Deformity
Enrollment 20 participants
Start Date 2026-03-01
Primary Completion 2026-07-30 (estimated)
Study Completion 2026-12-30 (estimated)
Updated on ClinicalTrials.gov 2026-08-04